Browse > Article
http://dx.doi.org/10.5653/cerm.2017.44.3.126

The association of follicular fluid volume with human oolemma stretchability during intracytoplasmic sperm injection  

Inoue, Taketo (Umeda Fertility Clinic)
Yamashita, Yoshiki (Umeda Fertility Clinic)
Tsujimoto, Yoshiko (Umeda Fertility Clinic)
Yamamoto, Shuji (Umeda Fertility Clinic)
Taguchi, Sayumi (Umeda Fertility Clinic)
Hirao, Kayoko (Umeda Fertility Clinic)
Uemura, Mikiko (Faculty of Rehabilitation, Kobe Gakuin University)
Ikawa, Kayoe (Umeda Fertility Clinic)
Miyazaki, Kazunori (Umeda Fertility Clinic)
Publication Information
Clinical and Experimental Reproductive Medicine / v.44, no.3, 2017 , pp. 126-131 More about this Journal
Abstract
Objective: Oocyte degeneration often occurs after intracytoplasmic sperm injection (ICSI), and the risk factor is low-quality oocytes. The follicular fluid (FF) provides a crucial microenvironment for oocyte development. We investigated the relationships between the FF volume aspirated from individual follicles and oocyte retrieval, oocyte maturity, oolemma stretchability, fertilization, and development. Methods: This retrospective study included data obtained from 229 ICSI cycles. Ovarian stimulation was performed according to a gonadotropin-releasing hormone antagonist protocol. Each follicle was individually aspirated and divided into six groups according to FF volume ( < 1.0, 1.0 to < 2.0, 2.0 to < 3.0, 3.0 to < 4.0, 4.0 to < 5.0, and ${\geq}5.0mL$). Oolemma stretchability during ICSI was evaluated using a mechanical stimulus for oolemma penetration, that is, the stretchability was assessed by oolemma penetration with aspiration (high stretchability) or without aspiration (low stretchability). Results: Oocyte retrieval rates were significantly lower in the < 1.0 mL group than in the ${\geq}1.0mL$ groups (46.0% [86/187] vs. 67.5%-74.3% [172/255 to 124/167], respectively; p< 0.01). Low oolemma stretchability was significantly more common in the < 1.0 mL group than in the ${\geq}1.0mL$ groups during ICSI (22.0% [13/59] vs. 5.8%-9.4% [6/104 to 13/139], respectively; p= 0.018). There was a relationship between FF volume and oolemma stretchability. However, there were no significant differences in the rates of fertilization, cleavage, ${\geq}7$ cells at day 3, and blastocyst development among all groups. Conclusion: FF volume is potentially associated with the stretchability of metaphase II oolemma during ICSI. Regarding oolemma stretchability, ensuring a uniform follicular size during ovarian stimulation is crucial to obtain good-quality oocytes.
Keywords
Fertilization; Gonadotropin-releasing hormone; Infertility; Membranes; Oocytes; Ovarian follicle; Ovulation induction; Sperm injections, Intracytoplasmic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Schipper I, Hop WC, Fauser BC. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab 1998;83:1292-8.
2 Mansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M, et al. Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril 2009;91:133-9.   DOI
3 Richter KS, Davis A, Carter J, Greenhouse SJ, Mottla GL, Tucker MJ. No advantage of laser-assisted over conventional intracytoplasmic sperm injection: a randomized controlled trial [NCT001 14725]. J Exp Clin Assist Reprod 2006;3:5.   DOI
4 Krause I, Pohler U, Grosse S, Shebl O, Petek E, Chandra A, et al. Characterization of the injection funnel during intracytoplasmic sperm injection reflects cytoplasmic maturity of the oocyte. Fertil Steril 2016;106:1101-6.   DOI
5 Ebner T, Moser M, Sommergruber M, Puchner M, Wiesinger R, Tews G. Developmental competence of oocytes showing increased cytoplasmic viscosity. Hum Reprod 2003;18:1294-8.   DOI
6 Iwayama H, Hochi S, Yamashita M. Low stretching ability of human oolemma during piezo-ICSI as a risk factor on post-injection survival and implantation. J Mamm Ova Res 2010;27:150-6.   DOI
7 Yanagida K, Katayose H, Suzuki K, Suganuma A, Sato A. Flexibility of oolemma is an important factor for oocyte survival after ICSI. J Mamm Ova Res 2001;18:93-8.   DOI
8 Mizobe Y, Oya N, Iwakiri R, Yoshida N, Sato Y, Onoue N, et al. Developmental ability of embryos produced from oocytes with fragile oolemma by intracytoplasmic sperm injection. J Assist Reprod Genet 2016;33:1685-90.   DOI
9 Commentary: oocyte degeneration after ICSI. J Reprod Stem Cell Biotechnol 2010;1:193-211.   DOI
10 Yavas Y, Roberge S, Khamsi F, Shirazi P, Endman MW, Wong JC. Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development. J Assist Reprod Genet 2001;18:426-35.   DOI
11 Hiraoka K, Kitamura S. Clinical efficiency of Piezo-ICSI using micropipettes with a wall thickness of 0.625 ${\mu}m$. J Assist Reprod Genet 2015;32:1827-33.   DOI
12 Rosen MP, Shen S, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Oocyte degeneration after intracytoplasmic sperm injection: a multivariate analysis to assess its importance as a laboratory or clinical marker. Fertil Steril 2006;85:1736-43.   DOI
13 Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40.   DOI
14 Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril 2015;103:303-16.   DOI
15 van Dessel HJ, Schipper I, Pache TD, van Geldorp H, de Jong FH, Fauser BC. Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles. Clin Endocrinol (Oxf) 1996;44:191-8.   DOI
16 Rodriguez-Fuentes A, Hernandez J, Garcia-Guzman R, Chinea E, Iaconianni L, Palumbo A. Prospective evaluation of automated follicle monitoring in 58 in vitro fertilization cycles: follicular volume as a new indicator of oocyte maturity. Fertil Steril 2010;93:616-20.   DOI
17 Mendoza C, Cremades N, Ruiz-Requena E, Martinez F, Ortega E, Bernabeu S, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod 1999;14:628-35.   DOI
18 Lamb JD, Zamah AM, Shen S, McCulloch C, Cedars MI, Rosen MP. Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection. Fertil Steril 2010;94:952-7.   DOI
19 Rosen MP, Shen S, Dobson AT, Rinaudo PF, McCulloch CE, Cedars MI. A quantitative assessment of follicle size on oocyte developmental competence. Fertil Steril 2008;90:684-90.   DOI
20 Salha O, Nugent D, Dada T, Kaufmann S, Levett S, Jenner L, et al. The relationship between follicular fluid aspirate volume and oocyte maturity in in-vitro fertilization cycles. Hum Reprod 1998;13:1901-6.   DOI
21 Inoue T, Ono Y, Emi N. Preservation of spermatozoa by refrigeration. In: Frias TA, Cano MJ, editors. Pregnancy: risk factors, management and recovery. New York: Nova Science Publishers; 2012. p. 121-46.
22 Inoue T, Sugimoto H, Okubo K, Emi N, Matsushita Y, Kojima K, et al. Successful pregnancy after intracytoplasmic sperm injection with testicular spermatozoa transported only under refrigeration. Reprod Med Biol 2010;9:173-7.   DOI
23 Lee TF, Lee RK, Hwu YM, Chih YF, Tsai YC, Su JT. Relationship of follicular size to the development of intracytoplasmic sperm injection-derived human embryos. Taiwan J Obstet Gynecol 2010;49:302-5.   DOI
24 Arashiro EK, Palhao MP, Wohlres-Viana S, Siqueira LG, Camargo LS, Henry M, et al. In vivo collection of follicular fluid and granulosa cells from individual follicles of different diameters in cattle by an adapted ovum pick-up system. Reprod Biol Endocrinol 2013;11:73.   DOI
25 Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, et al. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol 2008;31:691-6.   DOI
26 Penzias AS, Emmi AM, Dubey AK, Layman LC, DeCherney AH, Reindollar RH. Ultrasound prediction of follicle volume: is the mean diameter reflective? Fertil Steril 1994;62:1274-6.   DOI
27 Mehri S, Levi Setti PE, Greco K, Sakkas D, Martinez G, Patrizio P. Correlation between follicular diameters and flushing versus no flushing on oocyte maturity, fertilization rate and embryo quality. J Assist Reprod Genet 2014;31:73-7.   DOI
28 Liu X, Fernandes R, Jurisicova A, Casper RF, Sun Y. In situ mechanical characterization of mouse oocytes using a cell holding device. Lab Chip 2010;10:2154-61.   DOI
29 Yazbeck C, Ben Jamaa N, Hazout A, Cohen-Bacrie P, Junca AM, Rougier N. Advantages of the two-step embryo transfer strategy in human IVF/ICSI cycles. Zygote 2013;21:77-83.   DOI
30 Japan Society of Obstetrics and Gynecology. Prevention of multiple pregnancy in assisted reproductive technology. Acta Obstet Gynaecol Jpn 2014;8:1918.
31 Fanchin R, Schonauer LM, Cunha-Filho JS, Mendez Lozano DH, Frydman R. Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation. Semin Reprod Med 2005;23:354-62.   DOI
32 Liu X, Shi J, Zong Z, Wan KT, Sun Y. Elastic and viscoelastic characterization of mouse oocytes using micropipette indentation. Ann Biomed Eng 2012;40:2122-30.   DOI
33 Cota AM, Oliveira JB, Petersen CG, Mauri AL, Massaro FC, Silva LF, et al. GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology. Reprod Biol Endocrinol 2012; 10:33.   DOI
34 Ebner T, Balaban B, Moser M, Shebl O, Urman B, Ata B, et al. Automatic user-independent zona pellucida imaging at the oocyte stage allows for the prediction of preimplantation development. Fertil Steril 2010;94:913-20.   DOI
35 Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 1997;12:2359-65.   DOI